Vertex paused an early-stage trial of its inhaled treatment for cystic fibrosis that came from a partnership with Moderna.

The FDA on Tuesday said it is planning on doing more surprise inspections of foreign factories, a day after Trump signed an ...

House and Senate lawmakers from both parties are working with the Trump administration on proposals that would use drug ...

The European Union is committing €500 million ($556 million) over the next two years to make Europe a “magnet” for ...

NewLimit raises $130M Series B led by Kleiner Perkins to advance epigenetic reprogramming research for liver disease ...

Vertex said it's gathering momentum with its new product launches, building out new franchises with its sickle cell therapy ...

Several members of an FDA advisory committee warned on Monday that new data from studies on long-term use of opioids might ...

Deerfield Management is back with its third healthcare venture fund, this time securing more than $600 million to create new ...

Function Health is buying Ezra in a bid to create a haven for people who want copious amounts of data on their bodies. The ...

PTC Therapeutics announced Monday that its splicing drug for Huntington’s disease met the primary endpoint of a Phase 2 study ...

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

FDA delays Stealth BioTherapeutics PDUFA date amid questions about agency disruption, while other companies like Sanofi and J ...